Results 131 to 140 of about 2,835 (182)

Filgotinib Is an Effective and Safe Treatment Option for Difficult-To-Treat Ulcerative Colitis: Real-World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry. [PDF]

United European Gastroenterol J
Naber MR, van der Meulen AE, Voorneveld PW, Veltkamp SHC, van Bodegraven AA, Bodelier A, Mujagic Z, Pierik M, Verleye LMM, Duijvestein M, Bouwknegt DG, Visschedijk MC, Srivastava N, West RL, Oldenburg B, Löwenberg M, van Schaik FDM, Dutch ICC Registry.   +17 more
europepmc   +1 more source

Single-Cell Computational Frameworks for Quantifying BET Bromodomain Inhibitor Resistance and Screening Re-Sensitizer Drugs in Triple-Negative Breast Cancer. [PDF]

Adv Sci (Weinh)
Liu H, Yuan M, Shang Y, Chen J, Hou F, Wang L, Jiang W.   +6 more
europepmc   +1 more source

Updated review of Janus kinase inhibitors for the management of inflammatory bowel disease. [PDF]

World J Gastrointest Pharmacol Ther
Malakar S, Giri S, Jena A, Nath P.
europepmc   +1 more source

Corrigendum to "Preparation of colon-targeted pellets loaded with filgotinib/berberine hydrochloride and Their application in ulcerative colitis therapy" [International Journal of Pharmaceutics: X 2025 (10) 100415]. [PDF]

Int J Pharm X
Wang J, Kuang Z, Chen B, Yan C, Shi B, Li G.   +5 more
europepmc   +1 more source

Efficacy/Effectiveness, Safety and Treatment Persistence of Filgotinib in Rheumatoid Arthritis: A Narrative Review of Clinical Trials and Real-World Evidence. [PDF]

Rheumatol Ther
Tanaka Y, Taylor PC, Ritsema JAS, Kondo A, Kaise T.   +4 more
europepmc   +1 more source

JAK Inhibitors for Treatment of Pyoderma Gangrenosum and Sweet Syndrome: A Systematic Review of Published Case Reports. [PDF]

Dermatol Res Pract
Vahabi SM, Heidari S, Farahmand Y, Pourgholi E, Kianfar N, Memari H, Esmaeili F, Bahramian S, Etesami I, Ansari MS.   +9 more
europepmc   +1 more source

Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohort. [PDF]

Rheumatol Adv Pract
Nathan J, Farisogullari B, Jones N, Ayoub M, Brown J, Levy S, Brader J, Ersoy A, Israni B, Lloyd M, Latheef A, Hill D, Taylor A, Arachchige D, Chitsu H, Linklater H, Lather K, Gompels L, Elfar E, Malaiya R, Machado PM, Kiely PDW.   +21 more
europepmc   +1 more source

Janus Kinase Inhibitor Discontinuation at a UK Tertiary Centre: A Retrospective Study. [PDF]

Cureus
Bland K, Jubber A, Ganguly S, Moorthy A.
europepmc   +1 more source

Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab. [PDF]

Biologics
Otake H, Matsumoto S, Mashima H.
europepmc   +1 more source

Preparation of colon-targeted pellets loaded with filgotinib/berberine hydrochloride and Their application in ulcerative colitis therapy. [PDF]

Int J Pharm X
Wang J, Kuang Z, Chen B, Yan C, Shi B, Li G.   +5 more
europepmc   +1 more source